Discovery of Potent and Selective RSK Inhibitors as Biological Probes

While the p90 ribosomal S6 kinase (RSK) family has been implicated in multiple tumor cell functions, the full understanding of this kinase family has been restricted by the lack of highly selective inhibitors. A bis-phenol pyrazole was identified from high-throughput screening as an inhibitor of the...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2015-09, Vol.58 (17), p.6766-6783
Hauptverfasser: Jain, Rama, Mathur, Michelle, Lan, Jiong, Costales, Abran, Atallah, Gordana, Ramurthy, Savithri, Subramanian, Sharadha, Setti, Lina, Feucht, Paul, Warne, Bob, Doyle, Laura, Basham, Stephen, Jefferson, Anne B., Lindvall, Mika, Appleton, Brent A., Shafer, Cynthia M.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6783
container_issue 17
container_start_page 6766
container_title Journal of medicinal chemistry
container_volume 58
creator Jain, Rama
Mathur, Michelle
Lan, Jiong
Costales, Abran
Atallah, Gordana
Ramurthy, Savithri
Subramanian, Sharadha
Setti, Lina
Feucht, Paul
Warne, Bob
Doyle, Laura
Basham, Stephen
Jefferson, Anne B.
Lindvall, Mika
Appleton, Brent A.
Shafer, Cynthia M.
description While the p90 ribosomal S6 kinase (RSK) family has been implicated in multiple tumor cell functions, the full understanding of this kinase family has been restricted by the lack of highly selective inhibitors. A bis-phenol pyrazole was identified from high-throughput screening as an inhibitor of the N-terminal kinase of RSK2. Structure-based drug design using crystallography, conformational analysis, and scaffold morphing resulted in highly optimized difluorophenol pyridine inhibitors of the RSK kinase family as demonstrated cellularly by the inhibition of YB1 phosphorylation. These compounds provide for the first time in vitro tools with an improved selectivity and potency profile to examine the importance of RSK signaling in cancer cells and to fully evaluate RSK as a therapeutic target.
doi_str_mv 10.1021/acs.jmedchem.5b00450
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1711542958</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1711542958</sourcerecordid><originalsourceid>FETCH-LOGICAL-a414t-6526835ae9fc5bd89e08b82bb1735bdec932ab2f41cd76965f4a492d83df90a13</originalsourceid><addsrcrecordid>eNp9kMlOwzAQhi0EomV5A4R85JIy3rIcoRSoqERF4RzZjkNTJXGxk0p9ewxtOXIazcz_z_IhdEVgRICSW6n9aNWYQi9NMxIKgAs4QkMiKEQ8BX6MhgCURjSmbIDOvF8BACOUnaJBqCXASTxEk4fKa7sxbottiee2M22HZVvghamN7qqNwW-LFzxtl5WqOus8lh7fV7a2n5WWNZ47q4y_QCelrL253Mdz9PE4eR8_R7PXp-n4bhZJTngXxYLGKRPSZKUWqkgzA6lKqVIkYSE3OmNUKlpyooskzmJRcskzWqSsKDOQhJ2jm93ctbNfvfFd3oTzTV3L1tje5yQhRHCaiTRI-U6qnfXemTJfu6qRbpsTyH8A5gFgfgCY7wEG2_V-Q69C7890IBYEsBP82m3v2vDw_zO_ATt9fuY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1711542958</pqid></control><display><type>article</type><title>Discovery of Potent and Selective RSK Inhibitors as Biological Probes</title><source>MEDLINE</source><source>American Chemical Society Publications</source><creator>Jain, Rama ; Mathur, Michelle ; Lan, Jiong ; Costales, Abran ; Atallah, Gordana ; Ramurthy, Savithri ; Subramanian, Sharadha ; Setti, Lina ; Feucht, Paul ; Warne, Bob ; Doyle, Laura ; Basham, Stephen ; Jefferson, Anne B. ; Lindvall, Mika ; Appleton, Brent A. ; Shafer, Cynthia M.</creator><creatorcontrib>Jain, Rama ; Mathur, Michelle ; Lan, Jiong ; Costales, Abran ; Atallah, Gordana ; Ramurthy, Savithri ; Subramanian, Sharadha ; Setti, Lina ; Feucht, Paul ; Warne, Bob ; Doyle, Laura ; Basham, Stephen ; Jefferson, Anne B. ; Lindvall, Mika ; Appleton, Brent A. ; Shafer, Cynthia M.</creatorcontrib><description>While the p90 ribosomal S6 kinase (RSK) family has been implicated in multiple tumor cell functions, the full understanding of this kinase family has been restricted by the lack of highly selective inhibitors. A bis-phenol pyrazole was identified from high-throughput screening as an inhibitor of the N-terminal kinase of RSK2. Structure-based drug design using crystallography, conformational analysis, and scaffold morphing resulted in highly optimized difluorophenol pyridine inhibitors of the RSK kinase family as demonstrated cellularly by the inhibition of YB1 phosphorylation. These compounds provide for the first time in vitro tools with an improved selectivity and potency profile to examine the importance of RSK signaling in cancer cells and to fully evaluate RSK as a therapeutic target.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.5b00450</identifier><identifier>PMID: 26270416</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Animals ; Cell Line ; Crystallography, X-Ray ; Humans ; Male ; Mice ; Models, Molecular ; Phosphorylation ; Protein Conformation ; Pyrazoles - chemical synthesis ; Pyrazoles - chemistry ; Pyrazoles - pharmacology ; Pyridines - chemical synthesis ; Pyridines - chemistry ; Pyridines - pharmacology ; Pyrimidines - chemical synthesis ; Pyrimidines - chemistry ; Pyrimidines - pharmacology ; Rats, Sprague-Dawley ; Ribosomal Protein S6 Kinases, 90-kDa - antagonists &amp; inhibitors ; Signal Transduction ; Structure-Activity Relationship ; Y-Box-Binding Protein 1 - metabolism</subject><ispartof>Journal of medicinal chemistry, 2015-09, Vol.58 (17), p.6766-6783</ispartof><rights>Copyright © 2015 American Chemical Society</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a414t-6526835ae9fc5bd89e08b82bb1735bdec932ab2f41cd76965f4a492d83df90a13</citedby><cites>FETCH-LOGICAL-a414t-6526835ae9fc5bd89e08b82bb1735bdec932ab2f41cd76965f4a492d83df90a13</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.5b00450$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.5b00450$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26270416$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jain, Rama</creatorcontrib><creatorcontrib>Mathur, Michelle</creatorcontrib><creatorcontrib>Lan, Jiong</creatorcontrib><creatorcontrib>Costales, Abran</creatorcontrib><creatorcontrib>Atallah, Gordana</creatorcontrib><creatorcontrib>Ramurthy, Savithri</creatorcontrib><creatorcontrib>Subramanian, Sharadha</creatorcontrib><creatorcontrib>Setti, Lina</creatorcontrib><creatorcontrib>Feucht, Paul</creatorcontrib><creatorcontrib>Warne, Bob</creatorcontrib><creatorcontrib>Doyle, Laura</creatorcontrib><creatorcontrib>Basham, Stephen</creatorcontrib><creatorcontrib>Jefferson, Anne B.</creatorcontrib><creatorcontrib>Lindvall, Mika</creatorcontrib><creatorcontrib>Appleton, Brent A.</creatorcontrib><creatorcontrib>Shafer, Cynthia M.</creatorcontrib><title>Discovery of Potent and Selective RSK Inhibitors as Biological Probes</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>While the p90 ribosomal S6 kinase (RSK) family has been implicated in multiple tumor cell functions, the full understanding of this kinase family has been restricted by the lack of highly selective inhibitors. A bis-phenol pyrazole was identified from high-throughput screening as an inhibitor of the N-terminal kinase of RSK2. Structure-based drug design using crystallography, conformational analysis, and scaffold morphing resulted in highly optimized difluorophenol pyridine inhibitors of the RSK kinase family as demonstrated cellularly by the inhibition of YB1 phosphorylation. These compounds provide for the first time in vitro tools with an improved selectivity and potency profile to examine the importance of RSK signaling in cancer cells and to fully evaluate RSK as a therapeutic target.</description><subject>Animals</subject><subject>Cell Line</subject><subject>Crystallography, X-Ray</subject><subject>Humans</subject><subject>Male</subject><subject>Mice</subject><subject>Models, Molecular</subject><subject>Phosphorylation</subject><subject>Protein Conformation</subject><subject>Pyrazoles - chemical synthesis</subject><subject>Pyrazoles - chemistry</subject><subject>Pyrazoles - pharmacology</subject><subject>Pyridines - chemical synthesis</subject><subject>Pyridines - chemistry</subject><subject>Pyridines - pharmacology</subject><subject>Pyrimidines - chemical synthesis</subject><subject>Pyrimidines - chemistry</subject><subject>Pyrimidines - pharmacology</subject><subject>Rats, Sprague-Dawley</subject><subject>Ribosomal Protein S6 Kinases, 90-kDa - antagonists &amp; inhibitors</subject><subject>Signal Transduction</subject><subject>Structure-Activity Relationship</subject><subject>Y-Box-Binding Protein 1 - metabolism</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMlOwzAQhi0EomV5A4R85JIy3rIcoRSoqERF4RzZjkNTJXGxk0p9ewxtOXIazcz_z_IhdEVgRICSW6n9aNWYQi9NMxIKgAs4QkMiKEQ8BX6MhgCURjSmbIDOvF8BACOUnaJBqCXASTxEk4fKa7sxbottiee2M22HZVvghamN7qqNwW-LFzxtl5WqOus8lh7fV7a2n5WWNZ47q4y_QCelrL253Mdz9PE4eR8_R7PXp-n4bhZJTngXxYLGKRPSZKUWqkgzA6lKqVIkYSE3OmNUKlpyooskzmJRcskzWqSsKDOQhJ2jm93ctbNfvfFd3oTzTV3L1tje5yQhRHCaiTRI-U6qnfXemTJfu6qRbpsTyH8A5gFgfgCY7wEG2_V-Q69C7890IBYEsBP82m3v2vDw_zO_ATt9fuY</recordid><startdate>20150910</startdate><enddate>20150910</enddate><creator>Jain, Rama</creator><creator>Mathur, Michelle</creator><creator>Lan, Jiong</creator><creator>Costales, Abran</creator><creator>Atallah, Gordana</creator><creator>Ramurthy, Savithri</creator><creator>Subramanian, Sharadha</creator><creator>Setti, Lina</creator><creator>Feucht, Paul</creator><creator>Warne, Bob</creator><creator>Doyle, Laura</creator><creator>Basham, Stephen</creator><creator>Jefferson, Anne B.</creator><creator>Lindvall, Mika</creator><creator>Appleton, Brent A.</creator><creator>Shafer, Cynthia M.</creator><general>American Chemical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150910</creationdate><title>Discovery of Potent and Selective RSK Inhibitors as Biological Probes</title><author>Jain, Rama ; Mathur, Michelle ; Lan, Jiong ; Costales, Abran ; Atallah, Gordana ; Ramurthy, Savithri ; Subramanian, Sharadha ; Setti, Lina ; Feucht, Paul ; Warne, Bob ; Doyle, Laura ; Basham, Stephen ; Jefferson, Anne B. ; Lindvall, Mika ; Appleton, Brent A. ; Shafer, Cynthia M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a414t-6526835ae9fc5bd89e08b82bb1735bdec932ab2f41cd76965f4a492d83df90a13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Animals</topic><topic>Cell Line</topic><topic>Crystallography, X-Ray</topic><topic>Humans</topic><topic>Male</topic><topic>Mice</topic><topic>Models, Molecular</topic><topic>Phosphorylation</topic><topic>Protein Conformation</topic><topic>Pyrazoles - chemical synthesis</topic><topic>Pyrazoles - chemistry</topic><topic>Pyrazoles - pharmacology</topic><topic>Pyridines - chemical synthesis</topic><topic>Pyridines - chemistry</topic><topic>Pyridines - pharmacology</topic><topic>Pyrimidines - chemical synthesis</topic><topic>Pyrimidines - chemistry</topic><topic>Pyrimidines - pharmacology</topic><topic>Rats, Sprague-Dawley</topic><topic>Ribosomal Protein S6 Kinases, 90-kDa - antagonists &amp; inhibitors</topic><topic>Signal Transduction</topic><topic>Structure-Activity Relationship</topic><topic>Y-Box-Binding Protein 1 - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jain, Rama</creatorcontrib><creatorcontrib>Mathur, Michelle</creatorcontrib><creatorcontrib>Lan, Jiong</creatorcontrib><creatorcontrib>Costales, Abran</creatorcontrib><creatorcontrib>Atallah, Gordana</creatorcontrib><creatorcontrib>Ramurthy, Savithri</creatorcontrib><creatorcontrib>Subramanian, Sharadha</creatorcontrib><creatorcontrib>Setti, Lina</creatorcontrib><creatorcontrib>Feucht, Paul</creatorcontrib><creatorcontrib>Warne, Bob</creatorcontrib><creatorcontrib>Doyle, Laura</creatorcontrib><creatorcontrib>Basham, Stephen</creatorcontrib><creatorcontrib>Jefferson, Anne B.</creatorcontrib><creatorcontrib>Lindvall, Mika</creatorcontrib><creatorcontrib>Appleton, Brent A.</creatorcontrib><creatorcontrib>Shafer, Cynthia M.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jain, Rama</au><au>Mathur, Michelle</au><au>Lan, Jiong</au><au>Costales, Abran</au><au>Atallah, Gordana</au><au>Ramurthy, Savithri</au><au>Subramanian, Sharadha</au><au>Setti, Lina</au><au>Feucht, Paul</au><au>Warne, Bob</au><au>Doyle, Laura</au><au>Basham, Stephen</au><au>Jefferson, Anne B.</au><au>Lindvall, Mika</au><au>Appleton, Brent A.</au><au>Shafer, Cynthia M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Discovery of Potent and Selective RSK Inhibitors as Biological Probes</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2015-09-10</date><risdate>2015</risdate><volume>58</volume><issue>17</issue><spage>6766</spage><epage>6783</epage><pages>6766-6783</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>While the p90 ribosomal S6 kinase (RSK) family has been implicated in multiple tumor cell functions, the full understanding of this kinase family has been restricted by the lack of highly selective inhibitors. A bis-phenol pyrazole was identified from high-throughput screening as an inhibitor of the N-terminal kinase of RSK2. Structure-based drug design using crystallography, conformational analysis, and scaffold morphing resulted in highly optimized difluorophenol pyridine inhibitors of the RSK kinase family as demonstrated cellularly by the inhibition of YB1 phosphorylation. These compounds provide for the first time in vitro tools with an improved selectivity and potency profile to examine the importance of RSK signaling in cancer cells and to fully evaluate RSK as a therapeutic target.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>26270416</pmid><doi>10.1021/acs.jmedchem.5b00450</doi><tpages>18</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2015-09, Vol.58 (17), p.6766-6783
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_1711542958
source MEDLINE; American Chemical Society Publications
subjects Animals
Cell Line
Crystallography, X-Ray
Humans
Male
Mice
Models, Molecular
Phosphorylation
Protein Conformation
Pyrazoles - chemical synthesis
Pyrazoles - chemistry
Pyrazoles - pharmacology
Pyridines - chemical synthesis
Pyridines - chemistry
Pyridines - pharmacology
Pyrimidines - chemical synthesis
Pyrimidines - chemistry
Pyrimidines - pharmacology
Rats, Sprague-Dawley
Ribosomal Protein S6 Kinases, 90-kDa - antagonists & inhibitors
Signal Transduction
Structure-Activity Relationship
Y-Box-Binding Protein 1 - metabolism
title Discovery of Potent and Selective RSK Inhibitors as Biological Probes
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T13%3A40%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Discovery%20of%20Potent%20and%20Selective%20RSK%20Inhibitors%20as%20Biological%20Probes&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Jain,%20Rama&rft.date=2015-09-10&rft.volume=58&rft.issue=17&rft.spage=6766&rft.epage=6783&rft.pages=6766-6783&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.5b00450&rft_dat=%3Cproquest_cross%3E1711542958%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1711542958&rft_id=info:pmid/26270416&rfr_iscdi=true